Primary relevance to vitamin D Vitamin D is a stated subject of this paper.
Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.
Why this paper is included
Supporting source evidence:
The co‐primary outcomes to address this aim were: Assessment: Vitamin D evaluation at diagnosisManagement: Calcium and/or vitamin D optimisation, including dietary calcium intake, and/or bone‐protective agents at diagnosis as a composite outcome.
Source: Study Outcomes. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Study design awaiting verification.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.
Meta-analysis unclear · Blinding unclear / not reported · Human research reported
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
Eligible CS patients were aged ≥ 18 years, managed surgically or medically in the last 15 years, and achieved remission from hypercortisolaemia.
Source: Methods.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
Clinical Practice Patterns in Bone Health Assessment and Management in Endogenous Cushing's Syndrome
Study design awaiting verification · Clinical Endocrinology · 2025
Original publication title
Clinical Practice Patterns in Bone Health Assessment and Management in Endogenous Cushing's Syndrome
© 2025 The Author(s). Clinical Endocrinology published by John Wiley & Sons Ltd.
Original publication · Publisher record · CC BY 4.0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
Abstract: What objectives does the paper state?
Skeletal fragility is a common complication of endogenous Cushing's Syndrome (CS), although specific guidelines for managing bone health are lacking. This study aimed to assess clinicians' current engagement with bone health assessment and management in patients with endogenous CS.
Source: ObjectiveAbstract: Design
Retrospective‐cohort design.
Source: DesignAbstract: Patients
Seventy‐nine patients with confirmed endogenous CS, treated at a tertiary endocrine centre.
Source: PatientsAbstract: Measurements
The frequency of bone health assessment, evidenced by vitamin D measurement, and bone health management, evidenced by a composite outcome of calcium and/or vitamin D optimisation and/or initiation of bone‐protective agents, was recorded. Changes in bone mineral density (BMD), measured by Dual‐energy X‐ray absorptiometry (DEXA) and fracture prevalence were assessed pre‐ and post‐CS treatment.
Source: MeasurementsAbstract: Results
Vitamin D was measured in only 43% (34/79), and bone health was managed in only 39.2% (31/79). BMD was assessed in 44.3% (35/79) during active CS; of these, 22.9% had osteoporosis. Improved BMD was observed within a year of CS remission. Fractures occurred in 17.7% (14/79) within 2 years of CS diagnosis, and 12 additional fractures occurred during follow‐up despite CS remission. Treatment with bone‐protective agents expedited recovery with a significant increase in lumbar spine BMD, compared to those not treated.
Source: ResultsAbstract: Conclusions
Our data demonstrate that skeletal impairment and fragility fractures are highly prevalent in endogenous CS, and fracture risk may persist despite remission. However, currently, bone health is inadequately assessed and managed. These findings identify an urgent need for improved awareness, assessment, and management of bone‐health in this high‐risk population and call for specific evidence‐based practice guidelines.
Source: ConclusionsAuthors’ abstract
ABSTRACT
Objective
Skeletal fragility is a common complication of endogenous Cushing's Syndrome (CS), although specific guidelines for managing bone health are lacking. This study aimed to assess clinicians' current engagement with bone health assessment and management in patients with endogenous CS.
Design
Retrospective‐cohort design.
Patients
Seventy‐nine patients with confirmed endogenous CS, treated at a tertiary endocrine centre.
Measurements
The frequency of bone health assessment, evidenced by vitamin D measurement, and bone health management, evidenced by a composite outcome of calcium and/or vitamin D optimisation and/or initiation of bone‐protective agents, was recorded. Changes in bone mineral density (BMD), measured by Dual‐energy X‐ray absorptiometry (DEXA) and fracture prevalence were assessed pre‐ and post‐CS treatment.
Results
Vitamin D was measured in only 43% (34/79), and bone health was managed in only 39.2% (31/79). BMD was assessed in 44.3% (35/79) during active CS; of these, 22.9% had osteoporosis. Improved BMD was observed within a year of CS remission. Fractures occurred in 17.7% (14/79) within 2 years of CS diagnosis, and 12 additional fractures occurred during follow‐up despite CS remission. Treatment with bone‐protective agents expedited recovery with a significant increase in lumbar spine BMD, compared to those not treated.
Conclusions
Our data demonstrate that skeletal impairment and fragility fractures are highly prevalent in endogenous CS, and fracture risk may persist despite remission. However, currently, bone health is inadequately assessed and managed. These findings identify an urgent need for improved awareness, assessment, and management of bone‐health in this high‐risk population and call for specific evidence‐based practice guidelines.
Publication and source details
Original title: Clinical Practice Patterns in Bone Health Assessment and Management in Endogenous Cushing's Syndrome
Preeshila Behary; Dinushan Raveendran; Ramesh Nair; Aimee Di Marco; Debbie Papadopoulou; Florian Wernig; Ali Abbara; Karim Meeran; Niamh Martin; Jeremy Cox; Alexander N. Comninos
Clinical Endocrinology · 2025
* Correspondence: Alexander N. Comninos (a.comninos@imperial.ac.uk)© 2025 The Author(s). Clinical Endocrinology published by John Wiley & Sons Ltd.https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
Repository JATS snapshot; version as supplied
Source retrieved: 2026-11-10T23:59:02.651726+00:00
DOI: 10.1111/cen.70085 · PMC12954153